BeOne Medicines (ONC) Cash & Equivalents (2015 - 2026)
BeOne Medicines' (ONC) quarterly Cash & Equivalents came in at $5.1 billion in Q2 2026, up 84.98% year-over-year from $2.8 billion in Q2 2025, and up 6.39% quarter-over-quarter from $4.8 billion in Q1 2026.
Powered by 
Analysis
BeOne Medicines (ONC) Cash & Equivalents (2015 - 2026) Analysis & Trends
BeOne Medicines (ONC) has reported Cash & Equivalents for 12 consecutive years, with $5.1 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash & Equivalents rose 84.98% year-over-year to $5.1 billion in Q2 2026; TTM through Jun 2026 was $5.1 billion, a 84.98% increase from a year earlier, with the FY2025 full-year figure at $4.5 billion, up 73.08% from the prior year.
- Cash & Equivalents was $5.1 billion for Q2 2026 at BeOne Medicines, up from $4.8 billion in the prior quarter.
- Over five years, Cash & Equivalents peaked at $5.1 billion in Q2 2026 and troughed at $2.5 billion in Q1 2025.
- A 5-year average of $3.6 billion and a median of $3.5 billion in 2023 frame the typical range for Cash & Equivalents.
- Across the five-year window, Cash & Equivalents soared 203.41% in 2022 and dropped 26.92% in 2023, its largest moves.
- Over 5 years, Cash & Equivalents stood at $3.9 billion in 2022, then slipped by 18.03% to $3.2 billion in 2023, then dropped by 17.16% to $2.6 billion in 2024, then soared by 73.08% to $4.5 billion in 2025, then increased by 12.11% to $5.1 billion in 2026.
- The last three Cash & Equivalents figures came in at $5.1 billion (Q2 2026), $4.8 billion (Q1 2026), and $4.5 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 6.14 Bn |
| 10 | BeOne Medicines | 41.25 Bn | 36.15 Bn | 1.53 Bn | 5.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.10 Bn |
| Mar 31, 2026 | 4.79 Bn |
| Dec 31, 2025 | 4.55 Bn |
| Sep 30, 2025 | 4.04 Bn |
| Jun 30, 2025 | 2.76 Bn |
| Mar 31, 2025 | 2.52 Bn |
| Dec 31, 2024 | 2.63 Bn |
| Sep 30, 2024 | 2.70 Bn |
| Jun 30, 2024 | 2.59 Bn |
| Mar 31, 2024 | 2.79 Bn |
| Dec 31, 2023 | 3.17 Bn |
| Sep 30, 2023 | 3.07 Bn |
| Jun 30, 2023 | 3.41 Bn |
| Mar 31, 2023 | 3.54 Bn |
| Dec 31, 2022 | 3.87 Bn |
| Sep 30, 2022 | 4.20 Bn |
| Jun 30, 2022 | 4.53 Bn |
| Mar 31, 2022 | 4.35 Bn |
| Dec 31, 2021 | 4.38 Bn |
| Sep 30, 2021 | 1.38 Bn |
API Access
BeOne Medicines Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ONC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ONC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ONC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();